Episode
Episode 194 - Rick Batycky - CEO at Nocion Therapeutics
- Podcast
- The BioHub - by Avetix
- Published
- Jun 29, 2026
- Duration seconds
- 1759
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-194-rick-batycky-ceo-at-nocion-therapeutics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-194-rick-batycky-ceo-at-nocion-therapeutics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Rick Batycky, CEO of Nocion Therapeutics, joins The BioHub Podcast by Avetix to discuss the company’s work in chronic cough and neurogenic inflammation. Rick talks about the scale of the unmet need in chronic cough, why the condition remains so difficult to treat, and how Nocion is approaching the biology differently. He also shares insight into the company’s lead programme, its upcoming pivotal-stage development, and what successful execution could mean for patients who currently have limited treatment options. The conversation also explores Rick’s perspective on building a focused biotech, operating as a lean virtual organisation, working with regulators, and leading a team through late-stage clinical development.